Ovarian endometrioid tumors of low malignant potential: A clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma

Lawrence M. Roth, Robert Emerson, Thomas Ulbright

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Thirty cases of ovarian endometrioid tumor of low malignant potential (ETLMP) were studied and compared with 32 cases of well-differentiated endometrioid adenocarcinoma. ETLMP was distinguished from well-differentiated endometrioid adenocarcinoma by the absence of destructive stromal invasion, glandular confluence, or stromal disappearance. Intraepithelial carcinoma in a low malignant potential tumor was defined as areas showing grade 3 nuclei, sometimes associated with an intracystic villoglandular or cribriform pattern. Microinvasion in an ETLMP was defined as one or more areas of invasion with an area of ≤10 mm2. Because a cribriform pattern may be seen in purely intraglandular proliferations, the latter was not taken as evidence of invasion. The patients with ETLMP ranged from 28 to 86 years of age (mean 54.9 years), and only one patient (3%) had other than stage I disease at presentation. The patients with well-differentiated endometrioid carcinoma ranged from 26 to 87 years of age (mean 51.1 years), and three patients (9%) had stage II disease at presentation. An adenofibromatous pattern was present in 47% of cases of ETLMP and squamous differentiation in 47%; intraepithelial carcinoma occurred in 7% of cases and stromal microinvasion in 7%. None of these findings appeared to influence the prognosis because all patients with ETLMP were free of recurrent disease or metastasis on follow-up, whereas 20% of patients with well-differentiated endometrioid adenocarcinoma followed for >6 months developed recurrent disease. Thus, the prognosis of ETLMP, when defined by the above criteria, is favorable and is superior to that of well-differentiated endometrioid adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)1253-1259
Number of pages7
JournalAmerican Journal of Surgical Pathology
Volume27
Issue number9
DOIs
StatePublished - Sep 1 2003
Externally publishedYes

Fingerprint

Endometrioid Carcinoma
Neoplasms
Carcinoma in Situ
Neoplasm Metastasis

Keywords

  • Adenofibroma
  • Endometrioid adenocarcinoma
  • Endometrioid tumors of low malignant potential
  • Ovary

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

@article{2b2dd239fcdb445c88e2920e4e3396c5,
title = "Ovarian endometrioid tumors of low malignant potential: A clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma",
abstract = "Thirty cases of ovarian endometrioid tumor of low malignant potential (ETLMP) were studied and compared with 32 cases of well-differentiated endometrioid adenocarcinoma. ETLMP was distinguished from well-differentiated endometrioid adenocarcinoma by the absence of destructive stromal invasion, glandular confluence, or stromal disappearance. Intraepithelial carcinoma in a low malignant potential tumor was defined as areas showing grade 3 nuclei, sometimes associated with an intracystic villoglandular or cribriform pattern. Microinvasion in an ETLMP was defined as one or more areas of invasion with an area of ≤10 mm2. Because a cribriform pattern may be seen in purely intraglandular proliferations, the latter was not taken as evidence of invasion. The patients with ETLMP ranged from 28 to 86 years of age (mean 54.9 years), and only one patient (3{\%}) had other than stage I disease at presentation. The patients with well-differentiated endometrioid carcinoma ranged from 26 to 87 years of age (mean 51.1 years), and three patients (9{\%}) had stage II disease at presentation. An adenofibromatous pattern was present in 47{\%} of cases of ETLMP and squamous differentiation in 47{\%}; intraepithelial carcinoma occurred in 7{\%} of cases and stromal microinvasion in 7{\%}. None of these findings appeared to influence the prognosis because all patients with ETLMP were free of recurrent disease or metastasis on follow-up, whereas 20{\%} of patients with well-differentiated endometrioid adenocarcinoma followed for >6 months developed recurrent disease. Thus, the prognosis of ETLMP, when defined by the above criteria, is favorable and is superior to that of well-differentiated endometrioid adenocarcinoma.",
keywords = "Adenofibroma, Endometrioid adenocarcinoma, Endometrioid tumors of low malignant potential, Ovary",
author = "Roth, {Lawrence M.} and Robert Emerson and Thomas Ulbright",
year = "2003",
month = "9",
day = "1",
doi = "10.1097/00000478-200309000-00009",
language = "English (US)",
volume = "27",
pages = "1253--1259",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Ovarian endometrioid tumors of low malignant potential

T2 - A clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma

AU - Roth, Lawrence M.

AU - Emerson, Robert

AU - Ulbright, Thomas

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Thirty cases of ovarian endometrioid tumor of low malignant potential (ETLMP) were studied and compared with 32 cases of well-differentiated endometrioid adenocarcinoma. ETLMP was distinguished from well-differentiated endometrioid adenocarcinoma by the absence of destructive stromal invasion, glandular confluence, or stromal disappearance. Intraepithelial carcinoma in a low malignant potential tumor was defined as areas showing grade 3 nuclei, sometimes associated with an intracystic villoglandular or cribriform pattern. Microinvasion in an ETLMP was defined as one or more areas of invasion with an area of ≤10 mm2. Because a cribriform pattern may be seen in purely intraglandular proliferations, the latter was not taken as evidence of invasion. The patients with ETLMP ranged from 28 to 86 years of age (mean 54.9 years), and only one patient (3%) had other than stage I disease at presentation. The patients with well-differentiated endometrioid carcinoma ranged from 26 to 87 years of age (mean 51.1 years), and three patients (9%) had stage II disease at presentation. An adenofibromatous pattern was present in 47% of cases of ETLMP and squamous differentiation in 47%; intraepithelial carcinoma occurred in 7% of cases and stromal microinvasion in 7%. None of these findings appeared to influence the prognosis because all patients with ETLMP were free of recurrent disease or metastasis on follow-up, whereas 20% of patients with well-differentiated endometrioid adenocarcinoma followed for >6 months developed recurrent disease. Thus, the prognosis of ETLMP, when defined by the above criteria, is favorable and is superior to that of well-differentiated endometrioid adenocarcinoma.

AB - Thirty cases of ovarian endometrioid tumor of low malignant potential (ETLMP) were studied and compared with 32 cases of well-differentiated endometrioid adenocarcinoma. ETLMP was distinguished from well-differentiated endometrioid adenocarcinoma by the absence of destructive stromal invasion, glandular confluence, or stromal disappearance. Intraepithelial carcinoma in a low malignant potential tumor was defined as areas showing grade 3 nuclei, sometimes associated with an intracystic villoglandular or cribriform pattern. Microinvasion in an ETLMP was defined as one or more areas of invasion with an area of ≤10 mm2. Because a cribriform pattern may be seen in purely intraglandular proliferations, the latter was not taken as evidence of invasion. The patients with ETLMP ranged from 28 to 86 years of age (mean 54.9 years), and only one patient (3%) had other than stage I disease at presentation. The patients with well-differentiated endometrioid carcinoma ranged from 26 to 87 years of age (mean 51.1 years), and three patients (9%) had stage II disease at presentation. An adenofibromatous pattern was present in 47% of cases of ETLMP and squamous differentiation in 47%; intraepithelial carcinoma occurred in 7% of cases and stromal microinvasion in 7%. None of these findings appeared to influence the prognosis because all patients with ETLMP were free of recurrent disease or metastasis on follow-up, whereas 20% of patients with well-differentiated endometrioid adenocarcinoma followed for >6 months developed recurrent disease. Thus, the prognosis of ETLMP, when defined by the above criteria, is favorable and is superior to that of well-differentiated endometrioid adenocarcinoma.

KW - Adenofibroma

KW - Endometrioid adenocarcinoma

KW - Endometrioid tumors of low malignant potential

KW - Ovary

UR - http://www.scopus.com/inward/record.url?scp=0041887074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041887074&partnerID=8YFLogxK

U2 - 10.1097/00000478-200309000-00009

DO - 10.1097/00000478-200309000-00009

M3 - Article

C2 - 12960810

AN - SCOPUS:0041887074

VL - 27

SP - 1253

EP - 1259

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 9

ER -